$MANE


It is working on producing a drug coded VDPHL01 related to hair loss. Positive Phase 2/3 results show that the drug has moved one step closer to FDA approval and commercialization. Successful commercialization could take the current $3.5B market cap to a very different league. It also did dilution yesterday. Today it is rising too. If it succeeds in the story, the stock can rise to completely different prices and a multibagger is possible, but on the slightest failure news, drug fails, the story collapses
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments